FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3124774131> ?p ?o ?g. }

• W3124774131 endingPage "e001595" @default.
• W3124774131 startingPage "e001595" @default.
• W3124774131 abstract "The efficacy of cancer immunotherapy can be limited by the poor immunogenicity of cancer and the immunosuppressive tumor microenvironment (TME). Immunologically programming the TME and creating an immune-inflamed tumor phenotype is critical for improving the immune-responsiveness of cancers. Here, we interrogate the immune modulator Flagrp170, engineered via incorporation of a pathogen-associated molecular pattern (ie, flagellin) into an immunostimulatory chaperone molecule, in transforming poorly immunogenic tumors and establishing a highly immunostimulatory milieu for immune augmentation.Multiple murine cancer models were used to evaluate the immunostimulatory activity, antitumor potency, and potential side effects of Flagrp170 on administration into the tumors using a replication impaired adenovirus. Antibody neutralization and mice deficient in pattern recognition receptors, that is, toll-like receptor 5 (TLR5) and NOD like receptor (NLR) family caspase activation and recruitment domain (CARD) domain-containing protein 4 (NLRC4), both of which can recognize flagellin, were employed to understand the immunological mechanism of action of the Flagrp170.Intratumoral delivery of mouse or human version of Flagrp170 resulted in robust inhibition of multiple malignancies including head and neck squamous cell carcinoma and breast cancer, without tissue toxicities. This in situ Flagrp170 treatment induced a set of cytokines in the TME known to support Th1/Tc1-dominant antitumor immunity. Additionally, granulocyte macrophage colony-stimulating factor derived from mobilized CD8+ T cells was involved in the therapeutic activity of Flagrp170. We also made a striking finding that NLRC4, not TLR5, is required for Flagrp170-mediated antitumor immune responses.Our results elucidate a novel immune-potentiating activity of Flagrp170 via engaging the innate pattern recognition receptor NLRC4, and support its potential clinical use to reshape cancer immune phenotype for overcoming therapeutic resistance." @default.
• W3124774131 created "2021-02-01" @default.
• W3124774131 creator A5004090945 @default.
• W3124774131 creator A5004748269 @default.
• W3124774131 creator A5011771154 @default.
• W3124774131 creator A5016166287 @default.
• W3124774131 creator A5026949506 @default.
• W3124774131 creator A5029344793 @default.
• W3124774131 creator A5042783365 @default.
• W3124774131 creator A5056450685 @default.
• W3124774131 creator A5064069772 @default.
• W3124774131 creator A5068377419 @default.
• W3124774131 creator A5074932752 @default.
• W3124774131 creator A5076702481 @default.
• W3124774131 creator A5077799326 @default.
• W3124774131 creator A5080982053 @default.
• W3124774131 creator A5090638043 @default.
• W3124774131 date "2021-01-01" @default.
• W3124774131 modified "2023-09-25" @default.
• W3124774131 title "Immunologically programming the tumor microenvironment induces the pattern recognition receptor NLRC4-dependent antitumor immunity" @default.
• W3124774131 cites W1519633296 @default.
• W3124774131 cites W1532689189 @default.
• W3124774131 cites W16078583 @default.
• W3124774131 cites W1933265869 @default.
• W3124774131 cites W1975032025 @default.
• W3124774131 cites W1984484036 @default.
• W3124774131 cites W1987463569 @default.
• W3124774131 cites W2004630197 @default.
• W3124774131 cites W2020464162 @default.
• W3124774131 cites W2039123767 @default.
• W3124774131 cites W2069502810 @default.
• W3124774131 cites W2084388036 @default.
• W3124774131 cites W2086591619 @default.
• W3124774131 cites W2106089096 @default.
• W3124774131 cites W2109274792 @default.
• W3124774131 cites W2109485845 @default.
• W3124774131 cites W2113021258 @default.
• W3124774131 cites W2114601875 @default.
• W3124774131 cites W2117692326 @default.
• W3124774131 cites W2121626779 @default.
• W3124774131 cites W2123721949 @default.
• W3124774131 cites W2130153302 @default.
• W3124774131 cites W2130604054 @default.
• W3124774131 cites W2141904268 @default.
• W3124774131 cites W2155327161 @default.
• W3124774131 cites W2155510706 @default.
• W3124774131 cites W2156106286 @default.
• W3124774131 cites W2157837362 @default.
• W3124774131 cites W2160802204 @default.
• W3124774131 cites W2166969960 @default.
• W3124774131 cites W2408932313 @default.
• W3124774131 cites W2435243879 @default.
• W3124774131 cites W2508904605 @default.
• W3124774131 cites W2554479252 @default.
• W3124774131 cites W2556561046 @default.
• W3124774131 cites W2587048937 @default.
• W3124774131 cites W2655262992 @default.
• W3124774131 cites W2771899835 @default.
• W3124774131 cites W2778837083 @default.
• W3124774131 cites W2945996355 @default.
• W3124774131 cites W3019298395 @default.
• W3124774131 cites W4292337452 @default.
• W3124774131 doi "https://doi.org/10.1136/jitc-2020-001595" @default.
• W3124774131 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7817794" @default.
• W3124774131 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33468554" @default.
• W3124774131 hasPublicationYear "2021" @default.
• W3124774131 type Work @default.
• W3124774131 sameAs 3124774131 @default.
• W3124774131 citedByCount "7" @default.
• W3124774131 countsByYear W31247741312021 @default.
• W3124774131 countsByYear W31247741312022 @default.
• W3124774131 countsByYear W31247741312023 @default.
• W3124774131 crossrefType "journal-article" @default.
• W3124774131 hasAuthorship W3124774131A5004090945 @default.
• W3124774131 hasAuthorship W3124774131A5004748269 @default.
• W3124774131 hasAuthorship W3124774131A5011771154 @default.
• W3124774131 hasAuthorship W3124774131A5016166287 @default.
• W3124774131 hasAuthorship W3124774131A5026949506 @default.
• W3124774131 hasAuthorship W3124774131A5029344793 @default.
• W3124774131 hasAuthorship W3124774131A5042783365 @default.
• W3124774131 hasAuthorship W3124774131A5056450685 @default.
• W3124774131 hasAuthorship W3124774131A5064069772 @default.
• W3124774131 hasAuthorship W3124774131A5068377419 @default.
• W3124774131 hasAuthorship W3124774131A5074932752 @default.
• W3124774131 hasAuthorship W3124774131A5076702481 @default.
• W3124774131 hasAuthorship W3124774131A5077799326 @default.
• W3124774131 hasAuthorship W3124774131A5080982053 @default.
• W3124774131 hasAuthorship W3124774131A5090638043 @default.
• W3124774131 hasBestOaLocation W31247741311 @default.
• W3124774131 hasConcept C121608353 @default.
• W3124774131 hasConcept C136449434 @default.
• W3124774131 hasConcept C154317977 @default.
• W3124774131 hasConcept C170493617 @default.
• W3124774131 hasConcept C202751555 @default.
• W3124774131 hasConcept C203014093 @default.
• W3124774131 hasConcept C2776107976 @default.
• W3124774131 hasConcept C2776709828 @default.
• W3124774131 hasConcept C2777338127 @default.

• next